Brugada Syndrome in Pulmonary Embolism- Extremely Rare Presentation with Gradual Disappearance despite Later Conversions (Yasser's Conversions) and Yasser's Coving Sign Post- COVID-19 Pneumonia-New Discoveries
Yasser Mohammed Hassanain Elsayed
Introduction: Brugada syndrome (BrS) is an uncommon genetic disorder accountable for 4-12% SCDs
due to ventricular fibrillation. Brugada phenocopy (BrP) is a category of clinically diverse entities
causing identical Brugada-like electrocardiographic patterns to actual Brugada syndrome (BrS).
Till now, there has been no ECG decision even with application of the new criteria in differentiation
between BrS and BrP. Acute pulmonary embolism (PE) is a known serious cardiovascular and
respiratory disease. A scarce reports supporting Brugada syndrome post-acute respiratory SARS-CoV-2
(COVID-19) infection have been recorded. Case presentation: A 43-year-old, golden-furniture painter,
married male Egyptian heavy smoker patient was admitted to the hospital with pleural chest pain, fever,
tachypnea, and tachycardia. He was managed in the ICU for pulmonary embolism, Brugada syndrome,
and pneumonia. Conclusion: Acute pulmonary embolism is a new, rare presentation and sequel of
Brugada syndrome. Conversions (Yasser's Conversions) from Brugada syndrome type 1 to mixed type
with right reversal post-COVID-19 pneumonia and acute pulmonary embolism is an innovative finding.
The Coving Radiological Sign (Yasser's Coving Sign) is also a new radiological sign that is parallel to
the electrocardiographic coving configuration of Brugada syndrome. Fever is a predisposing factor and
an ominous sign for Brugada syndrome. Brugada syndrome and acute pulmonary embolism are a new
description of post-COVID-19 pneumonia.
